होम
एक्सप्लोर
nav.journalClub
ट्रेंडिंग
और
synapse
⌘+K
भाषा
हिन्दी
Adjuvant Chemotherapy After Curative Intent Resection of Ampullary Cancer (ADAPTA) | Synapse
March 14, 2026
Adjuvant Chemotherapy After Curative Intent Resection of Ampullary Cancer (ADAPTA)
BU
Bas A. Uijterwijk
Fondazione Poliambulanza Istituto Ospedaliero
DL
D. Lemmers
DK
Dorine S. Klei
University Medical Center Utrecht
See all
Key Points
To evaluate the effects of adjuvant chemotherapy following curative intent resection in patients with ampullary cancer.
Clinical trial enrollment and treatment assignment
Assessment of chemotherapy efficacy post-surgery
Monitoring patient outcomes and survival rates
Adjuvant chemotherapy shows potential benefits in improving survival rates
Outcomes following resection indicate the need for further studies
Assessment of treatment responses in varying cancer stages
Abstract
ClinicalTrials.gov Identifier: NCT06068023.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Uijterwijk et al. (Fri,) studied this question.
synapsesocial.com/papers/69b4ba3618185d8a39802eff
https://doi.org/https://doi.org/10.1097/coc.0000000000001271